Metraipolis › archive › dc_412e09b9f1bb

Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a post hoc analysis based on a phase III… — Europe PMC PMID:41567644

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41567644
DOI
10.3389/fphar.2025.1685072
License (as archived)
solo-consultazione
Archived
2026-11-07T01:14:29.387Z
SHA-256 of the archived text
11e2586fc1482273a481649fc63efd8fbd8d46841678b54dd81f0ba7a12902e2
Stable URL of this page
https://metraipolis.com/documento/dc_412e09b9f1bb

How to cite

Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a post hoc analysis based on a phase III… — Europe PMC PMID:41567644 — Europe PMC (en), https://europepmc.org/article/MED/41567644 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_412e09b9f1bb (Metraipolis archive dc_412e09b9f1bb, sha256 11e2586fc1482273a481649fc63efd8fbd8d46841678b54dd81f0ba7a12902e2)
BibTeX
@misc{dc412e09b9f1bb,
  title = {Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a post hoc analysis based on a phase III… — Europe PMC PMID:41567644},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41567644},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_412e09b9f1bb; sha256 11e2586fc1482273a481649fc63efd8fbd8d46841678b54dd81f0ba7a12902e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41567644. Agents can read the archived copy with the MCP tool read_document.